- Home
- Publications
- Publication Search
- Publication Details
Title
Activating STAT6 mutations in follicular lymphoma
Authors
Keywords
-
Journal
BLOOD
Volume 125, Issue 4, Pages 668-679
Publisher
American Society of Hematology
Online
2014-11-27
DOI
10.1182/blood-2014-06-582650
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cells
- (2014) U. Rozovski et al. BLOOD
- Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma
- (2014) H. Li et al. BLOOD
- Selective JAK2 Inhibition Specifically Decreases Hodgkin Lymphoma and Mediastinal Large B-cell Lymphoma Growth In Vitro and In Vivo
- (2014) Y. Hao et al. CLINICAL CANCER RESEARCH
- Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma
- (2014) Jay Gunawardana et al. NATURE GENETICS
- Genetics of Follicular Lymphoma Transformation
- (2014) Laura Pasqualucci et al. Cell Reports
- Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma
- (2013) A. Bouska et al. BLOOD
- Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma
- (2013) M. R. Green et al. BLOOD
- Cross Talk between Follicular Th Cells and Tumor Cells in Human Follicular Lymphoma Promotes Immune Evasion in the Tumor Microenvironment
- (2013) S. Rawal et al. JOURNAL OF IMMUNOLOGY
- Follicular lymphoma and the immune system: from pathogenesis to antibody therapy
- (2012) F. K. Stevenson et al. BLOOD
- The JAK-STAT Pathway at Twenty
- (2012) George R. Stark et al. IMMUNITY
- Current and future management of follicular lymphoma
- (2012) Gilles Salles et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Pathogenesis of follicular lymphoma
- (2012) Robert Kridel et al. JOURNAL OF CLINICAL INVESTIGATION
- Pathology, pathogenesis and molecular genetics of follicular NHL
- (2011) E. Leich et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Activation of STAT6 by STING Is Critical for Antiviral Innate Immunity
- (2011) Huihui Chen et al. CELL
- Phase II Study of Vorinostat for Treatment of Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma
- (2011) Mark Kirschbaum et al. JOURNAL OF CLINICAL ONCOLOGY
- Inactivating mutations of acetyltransferase genes in B-cell lymphoma
- (2011) Laura Pasqualucci et al. NATURE
- Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
- (2011) Ryan D. Morin et al. NATURE
- Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
- (2010) M. R. Green et al. BLOOD
- Acquired TNFRSF14 Mutations in Follicular Lymphoma Are Associated with Worse Prognosis
- (2010) K.-J. J. Cheung et al. CANCER RESEARCH
- Implications of the tumor microenvironment on survival and disease response in follicular lymphoma
- (2010) John G Gribben CURRENT OPINION IN ONCOLOGY
- Prognostic Factors in Follicular Lymphoma
- (2010) Thomas Relander et al. JOURNAL OF CLINICAL ONCOLOGY
- Live Cell Imaging Reveals Continuous STAT6 Nuclear Trafficking
- (2010) H.-C. Chen et al. JOURNAL OF IMMUNOLOGY
- Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent TFH–B cell axis
- (2010) C Pangault et al. LEUKEMIA
- Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
- (2010) Ryan D Morin et al. NATURE GENETICS
- Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma
- (2009) O. Ritz et al. BLOOD
- Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities
- (2009) A. Mottok et al. BLOOD
- STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line
- (2009) D Baus et al. LEUKEMIA
- Cytoprotective effects of IAPs revealed by a small molecule antagonist
- (2008) Stefanie Galbán et al. BIOCHEMICAL JOURNAL
- Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines
- (2008) D. Buglio et al. BLOOD
- IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma
- (2008) K. R. Calvo et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started